Advances in the treatment of Hodgkin lymphoma: Current and future approaches.

Ullah, Fauzia; Dima, Danai; Omar, Najiullah; Ogbue, Olisaemeka; Ahmed, Sairah.

Afiliação

Ullah F; Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, Cleveland, OH, United States.
Dima D; Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, Cleveland, OH, United States.
Omar N; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.
Ogbue O; Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, Cleveland, OH, United States.
Ahmed S; Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, Cleveland, OH, United States.

Front Oncol ; 13: 1067289, 2023.

Article em En | MEDLINE | ID: mdl-36937412

Palavras-chave

Classical Hodgkin lymphoma (cHL); chemoimmunotherapy; chimeric antigen receptor (CAR) T-cell therapy; hematopoietic stem cell transplant; relapsed and refractory Hodgkin's lymphoma

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article